 

Please forward this mail to the colleages you consider relevant for evaluation, discussion and
consideration for your clinical strategy for COVID-19.

Please let me know if additional informations are necessary.
To my person: | have MD PhD degree and have many years experience in pharmaceutical development
(Boehringer Ingelheim), Biotech (lgeneon, Aphton, Virologik GmbH) (for reference see also PubMed

Kircheis r) currently leading R&D activities at Syntacoll (part of Innocoll). | am providing this information
personally in order to help to find a treatment for COVID-19 patients.

Looking forward to getting feedback from you,
With kind regards,
Ralf Kircheis (MD PhD)

rkircheis@syntacoll.de

 
